Archives
Categories
Category Archives: News
New Drug for Hodgkin Lymphoma Has Been Fatal for PML Patients
ADCETRIS™ (generic name: brentuximab vedotin) is a new drug for treating Hodgkin Lymphoma (HL). On March 26, 2012, the makers …
Positive JCV Test Found As New Risk Factor for PML
Testing positive for anti-JC virus (JCV) antibodies is a newly identified risk factor for a rare, but serious brain disorder …
New Antibody Test Shown to Indicate PML Risk
If you test positive for having antibodies to the JC virus (JCV), you have an increased risk of getting progressive …
FDA Clears Phase II Trial of Drug to Treat JC Virus
The pharmaceutical company Inhibikase Therapeutics has received a green light from the U.S. Food and Drug Administration (FDA) to conduct …
Elan Profits Nearly Triple Thanks to MS Drug Sales
Second-quarter profits for the Irish drug company Elan came close to tripling due to hefty sales of Tysabri®, its drug …
One In 25,000 Patients Treated with Rituxan Risk PML
An arthritis patient on the medication Rituxan™ faces a one in 25,000 chance of getting the deadly brain disease progressive …